Document is current
Any future updates will be listed below
-
Authors
Robinson, Jill O.
Wynn, Julia
Biesecker, Barbara
Biesecker, Leslie G.
Bernhardt, Barbara
Brothers, Kyle B.
Chung, Wendy K.
Christensen, Kurt D.
Green, Robert C.
McGuire, Amy L.
Hart, M. Ragan
Griesemer, Ida
Patrick, Donald L.
Rini, Christine
Veenstra, David
Cronin, Angel M.
Gray, Stacy W.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (U01HG007307)
National Human Genome Research Institute (U01HG006507)
National Human Genome Research Institute (U01HG006500)
National Human Genome Research Institute (U01HG006546)
National Human Genome Research Institute (U01HG006492)
National Human Genome Research Institute (U01HG006487)
National Human Genome Research Institute (ZIAHG200359 09)
National Human Genome Research Institute (ZIAHG200387 04)
National Human Genome Research Institute (R21HG006596)
National Human Genome Research Institute (R01HG006600)
National Human Genome Research Institute (P50HG007257)
National Center for Advancing Translational Sciences (UL1TR000040)
National Center for Research Resources (UL1RR024156)
- License Information
-
More Information
Article History
Received: 1 February 2019
Accepted: 22 May 2019
First Online: 13 June 2019
Disclosure
: K.D.C. has received travel funds from Illumina, Inc. S.W.G. serves as a consultant to GRAIL. R.C.G. advises AIA, Applied Therapeutics, Helix, Ohana, OptraHealth, Prudential, Verily, and Veritas, and is cofounder of Genome Medical, Inc. Funding for B. Biesecker’s contributions came from the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. L.G.B. is a member of Illumina Medical Ethics Advisory Board, receives royalties from Genentech, receives in-kind research support from ArQule, Inc, honoraria from Cold Spring Harbor Press, and is supported by the Intramural Research Program of NHGRI, grant HG200387 04. The other authors declare no conflicts of interest.
